IL-17 has been implicated in several inflammatory disorders, such as rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, psoriasis, bronchial asthma, renal allograft rejection, and ankylosing spondylitis. Here, IL17A is linked to systemic lupus erythematosus.